The installation of the first HemoCell in Greece marked a significant milestone for both Werfen and Antisel.
The Werfen team has completed a major competitive conversion in North America, at CommonSpirit Health. As the second largest health system in the US, CommonSpirit comprises 142 hospitals across 21 states.
A selected group of distributors from Switzerland, South Africa and Romania and end-users from France, Switzerland and Romania were invited to join the EEMEA team in Basel for the Hemostasis Standardization Symposium.
In October, the EEMEA team promoted the new virtual reality (VR) application for HemoCell Specialized Lab Automation during 2 customer events in Hungary and Poland.
Like every story, this HemoCell story has beginning a middle and an end. This story begins a long time ago when Universitätspital Basel was still an opportunity that was above the funnel.
On April 9th and 10th, a significant group of partners and affiliate employees attended the EEMEAI Hemostasis Marketing Meeting. The days were structured in a way to reflect the slogan of the meeting and the Strategic positioning of the company by pulling on 5 levers of differentiation.

